Thermal Burn clinical trials at University of California Health
2 research studies open to eligible people
PermeaDerm® (PD) as Compared to Mepilex Ag®
open to eligible people ages up to 75 years
A total of 68 adult and pediatric patients who suffer from at least one discrete partial thickness thermal burn wound (Grade II) will be recruited. Subjects will be randomized (1:1) to either PermeaDerm® or Mepilex Ag®. Evaluations will occur at 7, 14 and 21 days with long term follow-up at 6 and 12 months.
at UC Davis
STAT: Standard Therapy Plus Active Therapy
open to eligible people ages 18-65
The objective of the study is to assess the efficacy of STAT, an activity-based therapy protocol compared to standard therapy (ST) to improve functional outcome and reduce disability in patients recovering from burn injury. This randomized multi-center trial is designed with two parallel treatment groups: STAT and ST. Efficacy of the STAT protocol will be determined through comparison to the ST only group. It will be conducted at seven burn centers.
at UC Davis
Our lead scientists for Thermal Burn research studies include Soman Sen, MD David Greenhalgh, M.D..
Last updated: